Early detection of familial ovarian cancer

European Journal of Cancer Part A

Volumn 32, Issue 10, 1996, Pages 1645-1651

  Dorum A ^a   Kristensen, G B ^a   Abeler, V M ^a   Trope C G ^a   Moller P ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Familial breast cancer; Familial ovarian cancer; Screening; Transvaginal ultrasonography

Indexed keywords

CA 125 ANTIGEN;

ARTICLE; BREAST CANCER; CANCER SCREENING; CLINICAL TRIAL; EARLY DIAGNOSIS; FAMILIAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY;

EID: 0006777028     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00137-2     Document Type: Article

References (27)

1. 1. Young RC, Perez CA, Hoskins WJ. Cancer of the ovary. In DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology, 4th edn. Philadelphia, Lippincott Co, 1993, 1226-1263.
2. 2. Engeland A, Haldorsen T, Tretli S, et al. Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. APMIS 1993, 101 (Suppl. 38), 62.
3. 3. Lynch HT, Bewtra C, Wells IC, Schuelke GS, Lynch JF. Hereditary ovarian cancer. In Lynch HT, Kullander S, eds. Cancer Genetics in Women. Boca Raton, CRC Press, 1987, Vol 1, 49-97.
4. 4. Hall JM, Lee MK, Morrow J, et al. Linkage analysis of early onset familial breast cancer to chromosome 17q21. Science 1990, 250, 1684-1689.
5. 5. Miki Y, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266, 66-71.
6. 6. Easton DF, Ford D, Bishop DT, and the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genetic 1993, 56, 265-271.
7. 7. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, and the Breast Cancer Linkage Consortium. Risks of cancer in BRCA1-mutation carriers. Lancet 1994, 343, 692-695.
8. 8. Cohen CJ, Jennings TS. Screening for ovarian cancer: the role of noninvasive imaging techniques. Am J Obstet Gynecol 1994, 170, 1088-1094.
9. 9. American College of Physicians. Screening for ovarian cancer: recommendations and rationale. Ann Intern Med 1994, 121, 141-142.
10. 10. DePriest PD, Van Nagell JR Jr, Gallion HH, et al. Ovarian cancer screening in asymptomatic postmenopausal women. Gynecol Oncol 1993, 51, 12-20.
11. 11. Droegemueller W. Screening for ovarian carcinoma: hopeful and wishful thinking. Am J Obstet Gynecol 1994, 170, 1095-1098.
12. 12. Granberg S, Wikland M. A comparison between ultrasound and gynecologic examination for detection of enlarged ovaries in a group of women at risk for ovarian cancer. J Ultrasound Med 1988, 7, 59-64.
13. 13. Bourne TH, Whitehead MI, Campbell S, Royston P, Bhan V, Collins WP. Ultrasound screening for familial ovarian cancer. Gynecol Oncol 1991, 43, 92-97.
14. 14. Bourne TH, Campbell S, Reynolds KM, et al. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. Br Med J 1993, 306, 1025-1029.
15. 15. Muto MG, Cramer DW, Brown DL, et al. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center. Gynecol Oncol 1993, 51, 12-20.
16. 16. Grover S, Quinn MA, Weideman P. Patterns of inheritance of ovarian cancer. An analyses from an ovarian cancer screening program. Cancer 1993, 72, 526-530.
17. 17. Karlan BY, Raffel LJ, Crvenkovic G, et al. A. multidisciplinary approach to the early detection of ovarian carcinoma: rationale, protocol design, and early results. Am J Obstet Gynecol 1993, 169, 494-500.
18. 18. Møller P. Genetic cancer: a challenge and a possible strategy. J Cancer Care 1993, 2, 94-99.
19. 19. Granberg S. Ultrasonographic diagnoses and treatment of ovarian cysts. In Rulin MC, ed. Clinical Obstetric and Gynecology. Philadelphia, Lippincott, 1993, 363-374.
20. 20. Nilsson O, Jansson EL, Dahlen U, Nilsson K, Nustad K, Lindholm L. New monoclonal antibodies for determination of the ovarian cancer associated antigen CA 125. In Klapdor R, ed. Current Tumour Diagnosis: Applications, Clinical Relevance, Research, Trends. Munchen, W. Zuckschwerdt Verlag GmbH 1994, 401-405.
21. 21. Serov SF, Scully RE, Sobin LH. Histological typing of ovarian tumors. In International Histological Classification of Tumors, No 9. Geneva, World Health Organization, 1973, 17.
22. 22. Saetersdal A, Dørum A, Heimdal K, et al. Early diagnosis of inherited breast cancer. Anticancer Res, in press.
23. 23. Amos CI, Shaw GL, Tucker MA, Hartge P. Age at onset for familial ovarian cancer. JAMA 1992, 268, 1896-1899.
24. 24. Mann WJ, Patsner B, Cohen H, Loesch M. Preoperative serum Ca-125 levels in patients with surgical stage I invasive ovarian adenocarcinoma. J Natl Cancer Inst 1988, 80, 208.
25. 25. Salazar H, Godwin AK, Daly M, Hogan M, Rosenblum N, Hamilton TC. Characterization of early benign and malignant ovarian neoplasms in prophylactic oophorectomy. Int J Gynecol Cancer 1993, 3 (Suppl.), 40.
26. 26. Cornelis RS, Cornelisse CJ, Devilee P. Selection of families for predictive testing for breast cancer. Lancet 1994, 344, 1151-1152.
27. 27. Meijer WJ, Van-Lindert AC. Prophylactic oophorectomy. Eur J Obstet Gynecol Reprod Biol 1992, 47, 59-65.